SOLUTION; INHALATION, INTRAVENOUS
| EQ 1GM BASE/5ML (EQ 200MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
| Discontinued
|
| PENTETATE CALCIUM TRISODIUM
| ytterbium DTPA
| HAMELN PHARMS
| 21749
2005-08-08 Letter 2004-10-20 Review 2004-08-11 Label 2004-08-11 Letter 2004-08-11 Other 2004-08-11 Other Important Information from FDA |